Skip to main content
Top
Published in: Clinical Phytoscience 1/2017

Open Access 01-12-2017 | Original Contribution

Canephron® N in the treatment of recurrent cystitis in women of child-bearing Age: a randomised controlled study

Authors: Maksim Sabadash, Alexander Shulyak

Published in: Clinical Phytoscience | Issue 1/2017

Login to get access

Abstract

Background

The aim of this study was to investigate the effect of the herbal medicine Canephron®N, particularly regarding its ability to prevent recurrences of cystitis, associated with E.Coli in women of child-bearing age.

Methods

Ninety patients were randomised into two treatment groups. Both, the test group (n = 45) and the control group (n = 45), received an antibacterial therapy (fluoroquinolones) for 7 days determined by urine culture. Furthermore, in both groups general recommendations on preventing cystitis were made (sufficient liquid consumption, avoidance of hypothermia etc.). The test group received an additional Canephron®N therapy for 3 months (2 tablets, three times a day).
Control examinations were conducted on day 7 and after 3, 6 and 12 months; or immediately in the case of a recurrent episode. The following cystitis symptoms were recorded at each time point: pain in the bladder, burning and stinging during urination, urinary urgency and frequent urination in small amounts. The criteria for defining a recurrent episode of cystitis were rebound lower urinary tract infection symptoms with pyuria and positive bacteriological urine culture.

Results

Canephron®N in addition to fluoroquinolones helps to reduce cystitis symptoms after 7 days better compared to treatment with fluoroquinolones only, as well as pyuria after 3, 6 and 12 months and urine levels of E. coli at 3 and 12 months.
The frequency rate of recurrent episodes of cystitis was in the test group always lower than in the control group with a statistically significant difference at 6 months (8.9% vs. 17.8%) and at 12 months (15.5% vs. 35.5%). At 12 months, the mean score of the LUTI Symptom Severity Index was 6 (p ≤ 0.05) in the control patients and 3 (p ≤ 0.05) in the test patients. This may indicate that the relapses were less severe in the test group.

Conclusion

Treatment with the herbal medicine Canephron®N is a novel treatment method of alleviating the symptoms of cystitis and especially for reducing the rate of recurrent cystitis episodes.
Literature
1.
go back to reference Nickel JC, Shoskes DA, Irvine-Bird K. Prevalence and impact of bacteriuria and/or urinary tract infection in interstitial cystitis/painful bladder syndrome. Urology. 2010;76:799–803.CrossRefPubMed Nickel JC, Shoskes DA, Irvine-Bird K. Prevalence and impact of bacteriuria and/or urinary tract infection in interstitial cystitis/painful bladder syndrome. Urology. 2010;76:799–803.CrossRefPubMed
3.
go back to reference Johansen TEB, Naber KG. Urinary tract infections. Antibiotics (Basel). 2014;3:375–7.CrossRef Johansen TEB, Naber KG. Urinary tract infections. Antibiotics (Basel). 2014;3:375–7.CrossRef
4.
go back to reference Grabe M, Bartoletti R, Bjerklund Johansen TE, Cai T, Çek M, Köves B, Naber KG, Pickard RS, Tenke P, Wagenlehner F, Wullt B. EAU guidelines on urological infections. European Association of Urology 2015: Arnhem; 2015. p. 1–78. Grabe M, Bartoletti R, Bjerklund Johansen TE, Cai T, Çek M, Köves B, Naber KG, Pickard RS, Tenke P, Wagenlehner F, Wullt B. EAU guidelines on urological infections. European Association of Urology 2015: Arnhem; 2015. p. 1–78.
5.
go back to reference Stanford E, McMurphy C. There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:551–4.CrossRefPubMed Stanford E, McMurphy C. There is a low incidence of recurrent bacteriuria in painful bladder syndrome/interstitial cystitis patients followed longitudinally. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:551–4.CrossRefPubMed
6.
go back to reference Abdul-Ghani AS, El-Lati SG, Sacaan A, et al. Anticonvulsant effects of some Arab medicinal plants. Int J Crude Drug Res. 1987;25:39–43.CrossRef Abdul-Ghani AS, El-Lati SG, Sacaan A, et al. Anticonvulsant effects of some Arab medicinal plants. Int J Crude Drug Res. 1987;25:39–43.CrossRef
7.
go back to reference Gracza L, Koch H, Löffler E. Isolierung von rosmarinsäure aus symphytum officinale und ihre antiinflammatorische wirksamkeit in einem in-vitro model. Arch Pharm. 1985;318:1090–5.CrossRef Gracza L, Koch H, Löffler E. Isolierung von rosmarinsäure aus symphytum officinale und ihre antiinflammatorische wirksamkeit in einem in-vitro model. Arch Pharm. 1985;318:1090–5.CrossRef
8.
go back to reference Haloui M, Louedec L, Michel B, Lyoussi B. Experimental diuretic effects of Rosmarinus officinalis und Centaurium erythrea. J Ethnopharmacol. 2000;71:465–72.CrossRefPubMed Haloui M, Louedec L, Michel B, Lyoussi B. Experimental diuretic effects of Rosmarinus officinalis und Centaurium erythrea. J Ethnopharmacol. 2000;71:465–72.CrossRefPubMed
9.
go back to reference Kumarasamy Y, Nahar L, Sarker SD. Bioactivity of gentiopicroside from the aerial parts of Centaurium erythrae. Fitoterapia. 2003;74:151–4.CrossRefPubMed Kumarasamy Y, Nahar L, Sarker SD. Bioactivity of gentiopicroside from the aerial parts of Centaurium erythrae. Fitoterapia. 2003;74:151–4.CrossRefPubMed
10.
go back to reference Naber G. Efficacy and safety of the phytotherapeutic drug canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in eastern Europe and central Asia. Res Rep Urol. 2013;5:39–46.PubMedPubMedCentral Naber G. Efficacy and safety of the phytotherapeutic drug canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in eastern Europe and central Asia. Res Rep Urol. 2013;5:39–46.PubMedPubMedCentral
Metadata
Title
Canephron® N in the treatment of recurrent cystitis in women of child-bearing Age: a randomised controlled study
Authors
Maksim Sabadash
Alexander Shulyak
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Clinical Phytoscience / Issue 1/2017
Electronic ISSN: 2199-1197
DOI
https://doi.org/10.1186/s40816-017-0046-7

Other articles of this Issue 1/2017

Clinical Phytoscience 1/2017 Go to the issue